Literature DB >> 27233967

IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.

Romain Loyon1, Emilie Picard1, Olivier Mauvais2, Lise Queiroz3, Virginie Mougey4, Jean-René Pallandre5, Jeanne Galaine1, Patricia Mercier-Letondal4, Guillaume Kellerman6, Nathalie Chaput7, John Wijdenes1, Olivier Adotévi8, Christophe Ferrand4, Pedro Romero9, Yann Godet1, Christophe Borg10.   

Abstract

NK cells are critical for innate immunity-mediated protection. The main roles of NK cells rely on their cytotoxic functions or depend on the tuning of Th1 adaptive immunity by IFN-γ. However, the precise influence of inflammatory cytokines on NK cell and CD4 T lymphocyte interactions was never investigated. In this study, we provide evidence that IL-21, a cytokine produced during chronic inflammation or infectious diseases, promotes the differentiation of a specific subset of NK cells coexpressing CD86 and HLA-DR and lacking NKp44. More importantly, IL-21-propagated HLA-DR(+) NK cells produce macrophage migration inhibitory factor and provide costimulatory signaling during naive CD4(+) T cell priming inducing the differentiation of uncommitted central memory T cells. Central memory T cells expanded in the presence of HLA-DR(+) NK cells are CXCR3(+)CCR6(-)CCR4(-)CXCR5(-) and produce IL-2, as well as low levels of TNF-α. Costimulation of CD4(+) T cells by HLA-DR(+) NK cells prevents the acquisition of effector memory phenotype induced by IL-2. Moreover, we identified this population of NK HLA-DR(+) macrophage migration inhibitory factor(+) cells in inflammatory human appendix. Collectively, these results demonstrate a novel function for IL-21 in tuning NK and CD4(+) T cell interactions promoting a specific expansion of central memory lymphocytes.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27233967     DOI: 10.4049/jimmunol.1501147

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.

Authors:  Emilie Picard; Yann Godet; Caroline Laheurte; Magalie Dosset; Jeanne Galaine; Laurent Beziaud; Romain Loyon; Laura Boullerot; Elodie Lauret Marie Joseph; Laurie Spehner; Marion Jacquin; Guillaume Eberst; Béatrice Gaugler; Françoise Le Pimpec-Barthes; Elizabeth Fabre; Virginie Westeel; Anne Caignard; Christophe Borg; Olivier Adotévi
Journal:  Oncoimmunology       Date:  2018-10-19       Impact factor: 8.110

2.  HLA-DR+ NK cells are mostly characterized by less mature phenotype and high functional activity.

Authors:  Sofya A Erokhina; Maria A Streltsova; Leonid M Kanevskiy; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  Immunol Cell Biol       Date:  2017-12-19       Impact factor: 5.126

Review 3.  NK cells in host responses to viral infections.

Authors:  Viola C Lam; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2016-12-13       Impact factor: 7.486

4.  FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC.

Authors:  Thomas E Bickett; Michael Knitz; Laurel B Darragh; Shilpa Bhatia; Benjamin Van Court; Jacob Gadwa; Shiv Bhuvane; Miles Piper; Diemmy Nguyen; Hua Tu; Laurel Lenz; Eric T Clambey; Kevin Barry; Sana D Karam
Journal:  Clin Cancer Res       Date:  2021-09-13       Impact factor: 12.531

5.  Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A.

Authors:  Maria A Streltsova; Sofya A Erokhina; Leonid M Kanevskiy; Dean A Lee; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

6.  NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.

Authors:  Elena Pontarini; Elisabetta Sciacca; Sofia Grigoriadou; Felice Rivellese; Davide Lucchesi; Liliane Fossati-Jimack; Rachel Coleby; Farzana Chowdhury; Francesca Calcaterra; Anwar Tappuni; Myles J Lewis; Martina Fabris; Luca Quartuccio; Silvia Della Bella; Simon Bowman; Costantino Pitzalis; Domenico Mavilio; Salvatore De Vita; Michele Bombardieri
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

7.  Complement-Opsonized HIV-1 Alters Cross Talk Between Dendritic Cells and Natural Killer (NK) Cells to Inhibit NK Killing and to Upregulate PD-1, CXCR3, and CCR4 on T Cells.

Authors:  Rada Ellegård; Mohammad Khalid; Cecilia Svanberg; Hanna Holgersson; Ylva Thorén; Mirja Karolina Wittgren; Jorma Hinkula; Sofia Nyström; Esaki M Shankar; Marie Larsson
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

8.  Porcine NK Cells Stimulate Proliferation of Pseudorabies Virus-Experienced CD8+ and CD4+CD8+ T Cells.

Authors:  Steffi De Pelsmaeker; Bert Devriendt; Nick De Regge; Herman W Favoreel
Journal:  Front Immunol       Date:  2019-01-17       Impact factor: 7.561

9.  Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets.

Authors:  Louise Magnusson; Hugo Barcenilla; Mikael Pihl; Sophie Bensing; Daniel Espes; Per-Ola Carlsson; Rosaura Casas
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

10.  PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates.

Authors:  Yago Pico de Coaña; Maria Wolodarski; Irene van der Haar Àvila; Takahiro Nakajima; Stamatina Rentouli; Andreas Lundqvist; Giuseppe Masucci; Johan Hansson; Rolf Kiessling
Journal:  Oncoimmunology       Date:  2020-08-28       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.